Air Freight for Pharmaceuticals From China: CEIV Pharma, Temperature Lanes and Active Containers

Moving finished pharmaceuticals, biologics or diagnostic kits by air from China to Bangladesh is not the same job as moving general cargo quickly. The product has a temperature specification it must never leave, a regulator that expects Good Distribution Practice, and a handful of points—the tarmac, the transit hub, the ramp at Dhaka—where the cold chain is most likely to break. This article explains the vocabulary you will meet when you book pharma air freight: CEIV Pharma, temperature lanes, and the choice between passive and active containers.

The two temperature lanes

Most pharmaceutical air freight moves in one of two ranges. The cold lane is 2 to 8 degrees Celsius, for vaccines, insulin, many biologics and some reagents. The controlled-room-temperature lane, usually written as 15 to 25 degrees Celsius (sometimes 15 to 30), is for a large share of tablets, capsules and liquids that must not freeze and must not cook. A smaller frozen lane, at minus 20 or below, exists for specific biologics. The product’s approved labelling defines which lane applies, and the packaging and container must hold that range for the whole door-to-door transit time plus a safety margin, because flights delay and hubs get hot.

The design question is always: what is the longest realistic transit, including a missed connection, and can the packout hold spec for that long? A solution rated for 72 hours on a route that normally takes 30 hours gives you room for one bad day. A solution rated for 36 hours on the same route does not.

CEIV Pharma: what the certification means

CEIV Pharma—the Center of Excellence for Independent Validators in Pharmaceutical Logistics—is an IATA programme that audits airlines, ground handlers, forwarders and airports against Good Distribution Practice and IATA’s Temperature Control Regulations. A CEIV-certified handler has documented cold-chain procedures, trained staff, temperature-controlled acceptance and build-up areas, and monitoring across the handling steps that would otherwise be blind spots.

For your shipment, a CEIV-certified origin station, carrier and—ideally—transit hub means the pallet is less likely to sit in the sun during build-up, more likely to be stored in a cool room during a layover, and handled by people who know a pharma ULD from a general one. It is not a guarantee, but on a route through a hot transit point it materially lowers the risk. Ask your forwarder which parties on your routing are CEIV certified.

Passive versus active containers

Passive solutions are insulated boxes and pallet shippers that hold temperature using pre-conditioned coolant—gel packs, phase-change material or dry ice—and good insulation, with no power and no moving parts. They are cheaper per shipment, simpler to handle, and fine for shorter transits and smaller volumes, but their hold time is fixed at packout: once the coolant is spent, the temperature drifts.

Active containers are powered units with a compressor or heater and a thermostat, such as the Envirotainer and CSafe container families, that actively maintain a setpoint for days and can be recharged or plugged in during transit. They cost more, need to be booked ahead and returned, and take up defined ULD positions, but they hold spec regardless of transit length and give you a data log. The rule of thumb: passive for short, small and cold-lane-tolerant; active for long transits, high value, tight tolerance or large volume where a single excursion would write off the consignment.

Where the chain breaks

The failure points on a China-Bangladesh pharma move are predictable:

• Origin build-up — pallet assembled in an un-airconditioned area and left on the tarmac before loading
• Transit hub — a missed connection turns a 4-hour layover into 18 hours; without cool storage the passive packout starts losing margin
• Dhaka arrival — cargo held on the ramp or in a warehouse without temperature control while documents clear
• Last mile — an ordinary van from the airport to the distributor in Dhaka traffic, with no cool box

A temperature logger in every shipment—and a documented plan for what happens if it shows an excursion—is the minimum. Our note on IoT temperature monitoring covers logger types, and cold-chain last-mile delivery in Dhaka covers the final leg.

Regulatory and documentation points

Pharmaceutical imports into Bangladesh are licensed by the Directorate General of Drug Administration, and the consignment needs its import authorisation, the manufacturer’s documentation and often batch and stability data. Diagnostic reagents and samples have their own handling rules—see air freight for medical samples and diagnostic reagents. If any component is classed as dangerous goods (dry ice is, and some reagents are), a dangerous-goods declaration and correct marking are mandatory. Build the regulatory paperwork before the flight, not after arrival, because pharma held on a hot ramp while an approval is chased is exactly the excursion you are trying to prevent. General perishable handling principles are in perishable cargo by air freight, and the broader distribution picture is in cold-chain compliance for pharmaceutical and vaccine distribution.

Qualifying a packout: the transit study

Before a passive packout is trusted on a route, it should be qualified against the worst realistic transit, not the brochure time. Map every leg from the origin plant to the Bangladesh distributor: factory to origin airport, acceptance and build-up, the flight, the transit hub layover, the flight to Dhaka, ground handling and customs at Dhaka, and the last mile to the warehouse. Add a missed connection at the hub—that single event often doubles the door-to-door time. If the packout is rated to hold the temperature range for that extended duration with margin to spare, it is fit for the lane. If it only just covers the normal transit, one bad day breaks it.

Season matters in this study. A packout conditioned and tested for a mild transit can behave differently when the origin apron and the Dhaka ramp are both hot. Ask the packaging supplier for the qualification data at the ambient profile your route actually sees, and re-check it if you switch routings or hubs.

Excursion response: what a good procedure contains

Every pharma shipment should arrive with a temperature record and a written plan for what happens if that record shows the range was breached. A workable procedure names who reviews the logger download on arrival, sets a quarantine step so suspect stock is held rather than distributed, defines who makes the release-or-reject decision (usually a qualified person on the importer or distributor side), and specifies the evidence to keep—the logger data, the packaging, photographs, the airway bill and handling records. It also sets the clock: claims against the carrier or handler have short deadlines, so the review cannot sit for a week.

The point of writing this down before the shipment is that an excursion is exactly the moment when improvised decisions go wrong—stock gets distributed that should have been held, or evidence that would have supported a claim is thrown away with the packaging.

We will not quote a lane rate, a container rental or a packout cost here, because they depend on the temperature range, the volume, the routing and the season—and a wrong number could lead you to under-spec the packaging on a consignment you cannot afford to lose. Tell us the product, the range and the volume and we will build a routing and packout plan with real figures. For temperature-controlled air freight from China, contact DE International — see our air freight and cold-chain services, our China buying-agent service, and the catalogue.